Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755911 · ClinicalTrials.gov registry record · Phase 1
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00755911 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 24 participants.
The verdict
NCT00755911, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Cell (TRC) Therapy.
Interventions
- DEVICE Control
- BIOLOGICAL Tissue Repair Cells (TRC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755911
The ClinicalTrials.gov registry entry for NCT00755911 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00755911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00755911 about?
NCT00755911 is a clinical study titled "Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy". The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Cell (TRC) Therapy.
What is the current status of trial NCT00755911?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00755911?
The interventions under investigation include: Control (DEVICE), Tissue Repair Cells (TRC) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00755911?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.